- BK21 Plus program
BK21 Plus program aims to Frontier Pharmacy Leaders in innovative drug discovery and development. This program has been provided with annual fund of 900 million won, about $5,000,000 for 7 years. This program is to foster creative next-generation researchers in Master’s, Doctorate and Post-doctoral researches.

- Medical Research Center (MRC)
Cancer Predisposing Network Research Center (cPRC) aims to develop core research areas with global competitiveness and improve national basic research capacity by discovering and fostering outstanding research groups with creativity and excellence. This program has been provided with annual fund of 1,000 million won during for 10 years.